Centiva Capital, LP Penumbra Inc Transaction History

Centiva Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$172.27 - $223.95 $27,218 - $35,384	158 Added 1.57%	10,233 $1.84 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $401,884 - $498,771	1,826 Added 22.14%	10,075 $2.25 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $1.23 Million - $1.76 Million	6,765 Added 455.86%	8,249 $2.07 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $72,447 - $101,969	301 Added 25.44%	1,484 $358,000
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $321,231 - $407,022	1,183 New	1,183 $407,000
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $110,469 - $133,632	-464 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $116,334 - $135,135	464 New	464 $124,000
Q2 2021 Aug 16, 2021	SELL	$235.0 - $310.7 $916,500 - $1.21 Million	-3,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$175.6 - $291.43 $684,840 - $1.14 Million	3,900 New	3,900 $1.06 Million

382

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.3B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.